1. Analysis of On-trial Quality Assurance for the SPARC Clinical Trial using Novel Peer-review Methodology. Issue 6 (June 2018) Authors: Holyoake, D.; Robinson, M.; Grose, D.; McIntosh, D.; Radhakrishna, G.; Sebag-Montefiore, D.; Hawkins, M. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combining interpolation and 3D level set method (I+3DLSM) for medical image segmentation. Issue 8 (1st April 2016) Authors: Doshi, T.; Di Caterina, G.; Soraghan, J.; Petropoulakis, L.; Grose, D.; MacKenzie, K.; Wilson, C. Journal: Electronics letters Issue: Volume 52:Issue 8(2016) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1136 Management SCC unknown primary with contemporary diagnostic and radiotherapy techniques. (April 2019) Authors: Paterson, C.; Crosbie, R.; McLoone, P.; Grose, D.; James, A.; Lamb, C.; Rizwanullah, M.; Schipani, S.; Wilson, C.; Campbell, F.; Easton, F.; Thomson, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1137 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study. (April 2019) Authors: Paterson, C.; McCrea, I.; Hay, L.; Allwood-Speirs, S.; Devlin, L.; Sankaralingam, M.; McLoone, P.; Wilson, C.; Grose, D.; James, A.; Lamb, C.; Rizwanullah, M.; Schipani, S.; Nixon, I.; Thomson, M.; McJury, M.; Foster, J.; Duffton, A. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1405 Feasibility study of fiducial markers in oesophageal cancer radiotherapy. (April 2019) Authors: Morton, A.; McIntosh, D.; Currie, S.; Stanley, A.J.; Paterson, S.; Grose, D.; Marashi, H.; MacLaren, V. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic. Issue 7 (July 2020) Authors: Aitken, K.; Good, J.; Hawkins, M.; Grose, D.; Mukherjee, S.; Harrison, M.; Radhakrishna, G. Journal: Clinical oncology Issue: Volume 32:Issue 7(2020) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis. (2020) Authors: Buettner, S.; Janssen, Q.; Suker, M.; Beumer, B.; Addeo, P.; Bachellier, P.; Bahary, N.; Bekaii-Saab, T.; Bali, M.; Besselink, M.; Boone, B.; Chau, I.; Clarke, S.; Dillhoff, M.; El-Rayes, B.; Frakes, J.; Grose, D.; Hosein, P.; Jamieson, N.; Javed, A. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neoadjuvant FOLFIRINOX treatment for borderline resectable pancreatic ductal adenocarcinoma: The pathological implications. (April 2016) Authors: Graham, J.; Jamieson, N.; Duthie, F.; Palani Velu, L.; Ali, C.; Maclaren, V.; Grose, D.; Mcintosh, D.; Mckay, C.J.; Dickson, E.; Carter, R. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-023 Real life application of the PET-Neck protocol for post radiotherapy surveillance in advanced HNSCC. (March 2019) Authors: Zhou, S.; Rulach, R.; Hendry, F.; Stobo, D.; Dempsey, M.F.; Grose, D.; Lamb, C.; James, A.; Schipani, S.; Rizwannullah, M.; Wilson, C.; Paterson, C. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC-024 12 week PET-CTs have a low PPV for nodal residual disease in HPV positive oropharygeal cancers. (March 2019) Authors: Rulach, R.; Zhou, S.; Hendry, F.; Stobo, D.; Dempsey, M.F.; Grose, D.; Lamb, C.; James, A.; Schipani, S.; Rizwanullah, M.; Wilson, C.; Paterson, C. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗